NON-ALCOHOLIC STEATOHEPATITIS
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug tame fatty liver disease?
Disease control OngoingThis study tests semaglutide, a diabetes medicine, in 1205 adults with non-cirrhotic NASH (a type of fatty liver disease). Participants inject the drug or a placebo once weekly for about 5 years. The goal is to see if semaglutide can reverse liver inflammation and scarring withou…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New sound wave device could spot fatty liver without needles
Diagnosis TerminatedThis study was designed to see if a new device that uses sound waves (thermo-acoustic imaging) can accurately measure fat in the liver. It planned to compare the device's results with standard MRI scans in adults with or suspected of having non-alcoholic fatty liver disease. The …
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC